Recently, China's intelligent robot research and development has achieved a world-class result. Professor Lu Peijun's research team of Peking University School of Stomatology successfully developed the world's first "tooth preparation small robot system", which uses automatic control of the femtosecond laser beam. Strictly according to the requirements of clinical medical standards and norms, accurately position and automatically complete the cutting and grinding of various dental treatments in the patient's mouth. When combined with other digital denture making equipment, the patient's denture repair treatment can be completed quickly. Greatly improve the treatment accuracy and work efficiency, shorten the treatment time, and improve the patient's medical comfort. The achievement has obtained 1 international invention patent, 8 domestic invention patents, 2 software application rights, 22 SCI/EI papers, and Scientific Reports in the British journal Nature. ) published 6 papers.

During the “Twelfth Five-Year Plan” period, the research and development of intelligent robots in the medical field in China has made great progress, and a series of research and development achievements with independent intellectual property rights have been obtained In the research and development of orthopedic robots, the research team of Professor Tian Wei from Beijing Jishuitan Hospital, together with Beijing University of Aeronautics and Astronautics and Beijing Tianzhihang Medical Technology Co., Ltd., formulated the first “Orthopedic Robot Product Standard” and developed the “GD2000 Orthopedic Robot Navigation and Positioning System”. "And "GD-S orthopedic robot navigation and positioning system", and used for daily surgery, filled the domestic gap. In the research and development of brain robots, the research team of Professor Tian Zengmin of the General Hospital of the Navy and the Beijing University of Aeronautics and Astronautics have successfully developed the robotic assisted brain surgery stereotactic surgery systems CRAS-BH1, CRAS-BH2, CRAS-BH3 and Liyuan BH-600. More than 5,000 cases of directional surgery were performed on various brain surgical diseases.

With the accelerating pace of innovation in artificial intelligence, digital manufacturing and mobile Internet innovation, intelligent robot technology and industry with functions of perception, recognition and cognition have become an important symbol for measuring the level of technological innovation and manufacturing in a country. At present, China's industrial robot research and development still has a big gap between the key components, products and industrialization and developed countries. However, the research and development achievements in the field of intelligent robots can become a breakthrough for the development of robots in China, and vigorously develop intelligent robot technology and industry to promote The reform of the supply-side structure, the nurturing of new technological development kinetic energy and new industries have great practical significance and need to be taken seriously from the national strategic level.

1. Increase support and promote the development of intelligent robot core technology. On the basis of the “Eleventh Five-Year Plan” and “Twelfth Five-Year Plan” for scientific and technological development planning and layout, during the “Thirteenth Five-Year Plan” period, we will focus on the frontiers and hotspots of intelligent robots, further consolidate and focus, increase financial support, and accelerate the development of core technologies. Break through the bottleneck of industrial technology and promote the development of intelligent robots for medical rehabilitation, family services, and public safety.

Amiodrone Intermediates

Dingmin Pharmaceutical supply Amiodrone API and Amiodrone Intermediates with high purity and best price. The main products CAS No are as follows: 1951-26-4, 52490-15-0. Sample can be sent if you request.

Welcome to do business with us. Please email to us directly.

4-Hydroxy-Benzoy1,Arrhythmia Intermediates,Cas 52490-15-0

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com